Luteolin was remarkable due to its strong binding to both MAPK1 for the downregulated genes and PIK3CA for upregulated genes across all BC subtypes, with binding scores of −9.1 and −8.4 kcal/mol, respectively. The gene discussed is MAPK1; the disease is breast cancer.